Buscar resultados de ensayos clínicos
Eosinophilic Esophagitis - 8 Studies Found
| Estado | Estudiar |
| NOT_YET_RECRUITING |
Nombre del estudio: Validation in French of a Quality of Life Questionnaire for Patients With Eosinophilic Esophagitis in Pediatrics Condición: Fecha: 2026-01-08 Intervenciones: Measurement of the quality of life of patients with eosinophilic esophagitis by the PedsQL questionnaire eosinophilic esophagitis module |
| Completed |
Nombre del estudio: A Study to Investigate Safety and Tolerability of NDX-3315 in Healthy Participants and Patients With Eosinophilic Esophagitis Condición: Eosinophilic Esophagitis Fecha: 2026-01-08 Intervenciones: Oral solution |
| Completed |
Nombre del estudio: Zemaira Eosinophilic Esophagitis Pilot Study Condición: Eosinophilic Esophagitis Fecha: 2026-01-08 Intervenciones: Intravenous infusion at 120 mg/kg body weight dose/week for 12 weeks for a total of 12 infusions. |
| Completed |
Nombre del estudio: Imaging of the Esophagus Using a SECM Capsule Condición: Eosinophilic Esophagitis Fecha: 2026-01-08 Intervenciones: Subjects will swallow a SECM capsule and the SECM imaging will be performed |
| Completed |
Nombre del estudio: A Study of CDX-0159 in Patients With Eosinophilic Esophagitis Condición: Eosinophilic Esophagitis Fecha: 2026-01-08 Intervenciones: subcutaneous administration |
| COMPLETED |
Nombre del estudio: Dose Escalation Study to Evaluate an Experimental New Treatment (CALY-002) in Healthy Subjects and Subjects With Celiac Disease and Eosinophilic Esophagitis Condición: Eosinophilic Esophagitis Fecha: 2026-01-08 Intervenciones: 1-hour intravenous infusion |
| COMPLETED |
Nombre del estudio: 24-Week Induction Study of APT-1011 in Adult Subjects with Eosinophilic Esophagitis (EoE) (FLUTE 3) Condición: Eosinophilic Esophagitis Fecha: 2026-01-08 Intervenciones: APT-1011 is an orally disintegrating tablet that includes fluticasone propionate as its active ingredient.Other Names:fluticasone pro |
| COMPLETED |
Nombre del estudio: Comparing the Extent to Which AQ280 is Made Available in the Body After Single Oral Doses of a Capsule Formulation Versus a Tablet for Oral Suspension Formulation Condición: Eosinophilic Esophagitis Fecha: 2026-01-08 Intervenciones: AQ280 administered orally in capsule formulation. |